Farde L - Search Results

1

Application of cross-species PET imaging to assess neurotransmitter release in brain.

Finnema SJ, Scheinin M, Shahid M, Lehto J, Borroni E, Bang-Andersen B, Sallinen J, Wong E, Farde L, Halldin C, Grimwood S. Finnema SJ, et al. Among authors: farde l. Psychopharmacology (Berl). 2015 Nov;232(21-22):4129-57. doi: 10.1007/s00213-015-3938-6. Epub 2015 Apr 30. Psychopharmacology (Berl). 2015. PMID: 25921033 Free PMC article. Review.

2

PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil.

Pauli S, Liljequist S, Farde L, Swahn CG, Halldin C, Litton JE, Sedvall G. Pauli S, et al. Among authors: farde l. Psychopharmacology (Berl). 1992;107(2-3):180-5. doi: 10.1007/BF02245135. Psychopharmacology (Berl). 1992. PMID: 1319600

3

[11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomography.

Halldin C, Farde L, Litton JE, Hall H, Sedvall G. Halldin C, et al. Among authors: farde l. Psychopharmacology (Berl). 1992;108(1-2):16-22. doi: 10.1007/BF02245279. Psychopharmacology (Berl). 1992. PMID: 1329130

4

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.

Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Farde L, et al. Arch Gen Psychiatry. 1992 Jul;49(7):538-44. doi: 10.1001/archpsyc.1992.01820070032005. Arch Gen Psychiatry. 1992. PMID: 1352677

5

PET studies of dopamine receptors in relation to antipsychotic drug treatment.

Farde L, Nordström AL, Halldin C, Wiesel FA, Sedvall G. Farde L, et al. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:468A-469A. doi: 10.1097/00002826-199201001-00244. Clin Neuropharmacol. 1992. PMID: 1354052 No abstract available.

6

Imaging of dopamine receptors using PET and SPECT.

Hall H, Farde L, Halldin C, Högberg T, Larsson S, Sedvall G. Hall H, et al. Among authors: farde l. Neurochem Int. 1992 Mar;20 Suppl:329S-333S. doi: 10.1016/0197-0186(92)90260-x. Neurochem Int. 1992. PMID: 1365450 Review. No abstract available.

7

Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brain.

Sedvall CG, Farde L, Hall H, Halldin C, Karlsson P, Brene S, Lindefors N, Persson H, Chipkin RE, Ehrlich M, et al. Sedvall CG, et al. Among authors: farde l. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:466A-467A. doi: 10.1097/00002826-199201001-00243. Clin Neuropharmacol. 1992. PMID: 1386781 No abstract available.

8

Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol.

Nordström AL, Farde L, Halldin C. Nordström AL, et al. Among authors: farde l. Psychopharmacology (Berl). 1992;106(4):433-8. doi: 10.1007/BF02244811. Psychopharmacology (Berl). 1992. PMID: 1533719

9

Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.

Farde L. Farde L. Psychopharmacology (Berl). 1992;107(1):23-9. doi: 10.1007/BF02244961. Psychopharmacology (Berl). 1992. PMID: 1534178

10

Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations.

Halldin C, Farde L, Barnett A, Sedvall G. Halldin C, et al. Among authors: farde l. Int J Rad Appl Instrum A. 1991;42(5):451-5. doi: 10.1016/0883-2889(91)90105-a. Int J Rad Appl Instrum A. 1991. PMID: 1646191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

434 results

Search Page

Filters